Tumor microcirculation and its significance in therapy: Possible role of omega-3 fatty acids as rheologicai modifiers

Medical Hypotheses

Volumn 50, Issue 2, 1998, Pages 175-182

  Baronzio, G F ^a,b,c,e   Galante, F ^a   Gramaglia, A ^c   Barlocco, A ^d   De Grandi, S ^a   Freitas, I ^b  

^a Oncology Section   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Lab for Molecular Biology Toma   (Italy)

^e Padre Pio Research di ISENT F   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD RHEOLOGY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; EXTRACELLULAR MATRIX; HUMAN; HYPERTHERMIC THERAPY; METASTASIS; MICROCIRCULATION; NONHUMAN; OXYGEN CONSUMPTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

EID: 0031885572     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90204-3     Document Type: Article

References (59)

1. Folkman J. The role of angiogenesis in tumor growth. Sem Cancer Biol 1992; 3: 65-71.
2. Dvorak H. Tumors: wounds that do not heal. N Engl J Med 1986; 315: 1650-1659.
3. Whalen G F. Solid tumors and wounds: transformed cells misunderstood as injured tissue? Lancet 1990; i: 1489-1492.
4. Vaupel P, Kallinowski F. Microcirculation and metabolic micromilieu in malignant tumors. Funktionsanalyse Fisiologischer Systeme 1988; 18: 265-271
5. Warren B A. The vascular morphology of tumors. In: Peterson H I, ed. Tumor Blood Circulation. Boca Raton, FL: CRC Press, 1979: 1-47.
6. Dewhirst M W. Angiogenesis and blood flow in solid tumors. In: Teicher B A, ed. Drug Resistance in Oncology. New York: Marcel Dekker, 1993: 3-24.
7. Dewhirst M W, Tso C Y, Oliver R et al. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Phys 1989; 17: 91-99.
8. Sevick E M, Jain R K. Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. Cancer Res 1989; 49: 3506-3512.
9. Jain R K. Determinants of tumor blood flow: a review. Cancer Res 1988; 48: 2641-2658.
10. Vaupel P, Kallinowski F. Hemoconcentration of blood flowing through human tumor xenografts. Int J Microcirc Clin Exp 1987; 6: 72.
11. Butler T P, Grantham F H, Gullino P M. Bulk transfer of fluid in the interstitial compartment of mammary tumor. Cancer Res 1975; 35: 3084-3088.
12. Sevick E M, Jain R K. Measurement of capillary filtration coefficient in a solid tumor. Cancer Res 1991; 51: 1352-1355.
13. Dvorak H F, Nagy J A, Berse B et al. Vascular permeability factor, fibrin and the pathogenesis of tumor stroma formation. Ann NY Acad Sci 1992; 667: 111-117.
14. Dvorak H. Thrombosis and cancer. Hum Pathol 1987; 18: 275-284.
15. Nand S, Messmore H. Hemostasis in malignancy. Am J Hematol 1990; 35: 45-55.
16. Freitas I, Baronzio G F, Bertone V et al. Stroma formation in Ehrlich carcinoma, I: Oedema phase: a mitosis burst as an index of physiological reoxygenation? Anticancer Res 1991; 11: 569-578.
17. Dintenfass L. Hyperviscosity of blood and its relationship to microcirculation efficiency. In: Stuart J S, ed. Drugs and The Delivery of Oxygen to Tissues. Boca Raton, FL: CRC Press, 1990: 107-134.
18. Sutherland R M. Cell and environment interaction in tumor microregions: the multicell spheroid model. Science 1988; 240: 177-184.
19. Sevick E M, Jain R K. Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity. Cancer Res 1989; 49: 3513-3519.
20. Cohen M H. Impairment of red blood cell deformability by tumor growth. J Natl Cancer Inst 1979; 63: 525-526.
21. Sasaki A, Jain R, Maghazachi A A, Goldfarb R H, Herberman R B. Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. Cancer Res 1989; 49: 3742-3746.
22. Kuzu I, Bicknell R, Fletcher C D M, Gatter R C. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 1993; 69: 332-328.
23. Gullino P M. Extracellular compartments of solid tumors. In: Becker F B, ed. Cancer: A Comprehensive Treatise, Vol. 3: Biology of Tumors: Cellular Biology and Growth. New York: Plenum, 1975: 327-354.
24. Gullino P M. Prostaglandins and gangliosides of tumor microenvironment: their role in angiogenesis. Acta Oncol 1995; 34: 439-441.
25. Gullino P M, Grantham F H. The influence of the host and the neoplastic cell population on the collagen content of a tumor mass. Cancer Res 1963; 23: 648-653.
26. Boucher Y, Less J R, Posner M C, Walmark N, Jain R K. Interstitial hypertension in human primary and metastatic tumors. In: Chapman J D, Dewey W C, Whitmore G F, eds. Radiation Research: A Twentieth Century Prospective, Vol. 1. San Diego, CA: Academic Press, 1991: 465.
27. Gutman R, Leuning M, Feyh J et al. Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res 1992; 52: 1993-1995.
28. Jain R K. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039-3051.
29. Curti B D. Physical barriers to drug delivery in tumors. Crit Rev Oncol Hematol 1993; 14: 29-39.
30. Coleman C N, Beard C J, Hlatky L, Kwok T T, Bump E. Biochemical modifiers: hypoxic cells sensitizers. In: Mauch Loeffler, eds. Radiation Oncology: Technology and Biology. Philadelphia: Saunders, 1994: 56-89.
31. Wilson R E, Keng P C, Sutherland R M. Changes in growth characteristics and macromolecular synthesis on recovery from severe hypoxia. Br J Cancer 1989; 61: 14-21.
32. Hill R P. Cellular basis of radiotherapy. In: Tannock I F, Hill P P, eds. The Basic Science of Oncology. New York: MacGraw-Hill, 1992: 259-276.
33. Young S D, Hill R P. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst 1990; 82: 371-380.
34. Brown J M. Tumor hypoxia, drug resistance and metastases. J Natl Cancer Inst 1990; 82: 338-339.
35. Jain R K, Baxter L T. Mechanism of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 1988; 48: 7022-7032.
36. Cobb L M. Intratumor factors influencing the access of antibody to tumour cells. Cancer Immunol Immunother 1989; 28: 235-240.
37. Pontiggia P, McLaren J R, Baronzio G F, Freitas I. The biological responses to heat. In: Bicher H I, McLaren J R, Pigliucci G M, eds. Consensus in Hyperthermia for the 1990s: Clinical Practice in Cancer Treatment. New York: Plenum, 1990: 271-291.
38. Jain R K, Ward-Hartley K. Tumor blood flow - characterization, modifications, and role in hyperthermia. IEEE Trans Sonics Ultrasonics 1984; SU 31: 504-526.
39. Freitas I, Baronzio G F. Tumor hypoxia, reoxygenation and oxygenation strategies: possible role in photodynamic therapy. J Photochem Photobio B: Biol 1991; 11: 3-30.
40. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-6465.
41. Freitas I, Pontiggia P, Baronzio G F, McLaren J R. Perspectives for the combined use of photodynamic therapy and hyperthermia in cancer patient. In: Bicher H I, McLaren J R, Pigliucci G M, eds. Consensus in Hyperthermia for the 1990s: Clinical Practice in Cancer Treatment. New York: Plenum, 1990: 511-520.
42. 2 availability during hemodilution. In: Deweley D, Bicherb H, Reneau D, eds. Oxygen Transport To Tissues VI. New York: Plenum, 1986: 281-291.
43. Wood P J, Hirst D G. Cinnarizine and flunarizine as radiation sensitisers in two murine tumours. Br J Cancer 1988; 58: 742-745.
44. Hoess D J, Dennis I F, Bleehen N M. Pentoxifylline: its pharmacokinetics and ability to improve tumor perfusion and radiosensitivity in mice. Radiother Oncol 1993; 28: 208-218.
45. 2 saturation in RIF-1 or KHT sarcomas. Int J Radiat Oncol Biol Phys 1992; 22: 447-450.
46. Sagar S M, Klassen G A, Barklay K D, Aldrich J E. Tumor blood flow: measurement and manipulation for therapeutic gain. Cancer Treat Rev 1993; 19: 299-349.
47. Ward K A, Jain R K. Response of tumours to hyperglycaemia: characterization, significance and role in hyperthermia. Int J Hyperthermia 1988; 4: 223-250.
48. Suzuki M, Hori H, Tanda S, Sato H. Functional characterization of the microcirculation in tumors. Cancer Metast Rev 1984; 3: 115-126.
49. Radack K, Deck C C, Huster G A. Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double blind controlled study. Ann Intern Med 1989; 111: 757-758.
50. Ernst E. Effects of n-3 fatty acids on blood rheology. J Intern Med 1989; 225(suppl.):129-132.
51. Knapp H R, Reilly I A G, Alessandrini P, Fitgerald G A. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986; 314: 937-942.
52. Leaf A. Cardiovascular effects of fish oils: beyond the platelet. Circulation 1990; 82: 624-628.
53. Terano T, Hirai A, Hamazaki T et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983; 46: 321-323.
54. Woodcock B E, Smith E, Lambert W H et al. Beneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J 1984; 288: 592-594.
55. Berlin E, Bhahena S J, Judd J T et al. Effects of omega-3 fatty acid and vitamin E supplementation on erythrocyte membrane fluidity, tocopherols, insulin binding and lipid composition in adult men. J Nutr Biochem 1992; 3: 392-400.
56. Sagar S M, Gurmit S, Hodson D I, Whitton A C. Nitric oxide and anti-cancer therapy. Cancer Treatment Rev 1995; 21: 159-181.
57. Israel D H, Gorlin R. Fish oil in prevention of atherosclerosis. J Am Coll Cardiol 1992; 19: 174-185.
58. Doi K, Akaike T, Horie H et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 1996; 80(suppl II): 1598-1604.
59. Jaakkola K, Lahteenmaki P, Laaskso J et al. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res 1992; 12: 599-606.